Back

Patients with a CHAD2-VASC score 1 : anticoagulation or not?

29 August 2016 (16:52 - 17:15)
Organised by:
Congress Presentation Part of: Atrial fibrillation Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Xingpeng Liu

Beijing Chaoyang Hospital, Beijing (China)

3 More presentations in this session

Presentation thumbnail
Non valvular atrial fibrillation: what's that?
Professor J. Camm (London, GB)
Slides Video
Presentation thumbnail
Anticoagulation and duration of atrial fibrillation episodes
Professor J. Le Heuzey (Paris, FR)
Slides Video
Presentation thumbnail
Atrial fibrosis and atrial fibrillation
Doctor M. Chen (Jiangsu, CN)
Slides Video

Access the full session

Session thumbnail
Atrial fibrillation

The Event

Event poster

ESC Congress 2016

29 August 2016 16:52 CET
You may be interested in
thumbnail
Congress Presentation
When not to start oral anticoagulation in CHA2DS2-VASc 1 - patients.
3 April 2022
thumbnail
Congress Presentation
CHA2DS2-VASc score predicts periprocedural complications and mortality of percutaneous coronary intervention irrespective of atrial fibrillation: a systematic review and meta-analysis
8 March 2024
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources